Zymeworks enters license deal for ZW209 with Roche
Zymeworks announced an exclusive global license and collaboration agreement for ZW209, a now received $55 million upfront. The deal has potential total value of over $800 million.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed